Home ›
Entities
› academia
› EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients
EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients
Research article (Kidney International, 2020) · cited 42× · AI/ML
EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients
Summary
EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients is a scholarly article[1].
Key Facts
EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients. Retrieved May 24, 2026, from https://4ort.xyz/entity/eos789-a-broad-spectrum-inhibitor-of-phosphate-transport-is-safe-with-an-indication-of-efficacy-in-a-phase-1b-randomized
MLA“EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/eos789-a-broad-spectrum-inhibitor-of-phosphate-transport-is-safe-with-an-indication-of-efficacy-in-a-phase-1b-randomized.
BibTeX@misc{4ortxyz_eos789-a-broad-spectrum-inhibitor-of-phosphate-transport-is-safe-with-an-indication-of-efficacy-in-a-phase-1b-randomized_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients}}, year = {2026}, url = {https://4ort.xyz/entity/eos789-a-broad-spectrum-inhibitor-of-phosphate-transport-is-safe-with-an-indication-of-efficacy-in-a-phase-1b-randomized}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients — https://4ort.xyz/entity/eos789-a-broad-spectrum-inhibitor-of-phosphate-transport-is-safe-with-an-indication-of-efficacy-in-a-phase-1b-randomized (retrieved 2026-05-24)
